Accelerate Diagnostics Inc
AXDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$859.92K
Close$
$1.86
5377.4% upside
Current Fair Value
5377.4% upsideUndervalued by 5377.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $859,918.00 |
|---|---|
| Enterprise Value | $50.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.15 |
| Beta | 0.22 |
| Outstanding Shares | 23,302,000 |
Return
| Return on Equity | 89.30% |
|---|---|
| Return on Assets | -175.26% |
| Return on Invested Capital | 1230.62% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 4.34 |
| Enterprise Value to EBIT | -1.56 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.28 |
| Debt to Equity | -1.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 5, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Accelerate Diagnostics, Inc.
107 employees
CEO: Mr. Jack Phillips Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnost...